Loading clinical trials...
Loading clinical trials...
In the UK there are over 7,000 leg amputations each year because of diabetes. The most important cause of this is poor circulation. The detection of poor circulation in patients with diabetes is difficult. A number of tests exist to detect poor circulation (known as peripheral arterial disease (PAD)). However, there is confusion as to which is the gold standard. The DM PAD study aims to determine the diagnostic performance of index tests (audible handheld Doppler, visual handheld Doppler, ankle brachial pressure index (ABPI), exercise ABPI and toe brachial pressure index (TBPI)) for the diagnosis of PAD in patients with diabetes as determined by a reference test (CTA or MRA).
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Mid and South Essex NHS Foundation Trust
Basildon, United Kingdom
Cardiff and Vale UHB
Cardiff, United Kingdom
University Hospitals of Derby and Burton NHS Foundation Trust
Derby, United Kingdom
NHS Greater Glasgow and Clyde
Glasgow, United Kingdom
Hull University Teaching Hospitals NHS Trust
Hull, United Kingdom
University Hospitals of Leicester NHS Trust
Leicester, United Kingdom
Central London Community Healthcare NHS Trust sites
London, United Kingdom
Chelsea and Westminster Hospital NHS Foundation Trust
London, United Kingdom
St George's University Hospitals NHS Foundation Trust
London, United Kingdom
Imperial College Healthcare NHS Trust
London, United Kingdom
Start Date
March 14, 2022
Primary Completion Date
February 28, 2024
Completion Date
February 28, 2024
Last Updated
September 3, 2025
604
ACTUAL participants
Toe Brachial Pressure Index (TBPI)
DIAGNOSTIC_TEST
Ankle Brachial Pressure Index (ABPI)
DIAGNOSTIC_TEST
Exercise Ankle Brachial Pressure Index (ABPI)
DIAGNOSTIC_TEST
Audible handheld Doppler
DIAGNOSTIC_TEST
Visual handheld Doppler
DIAGNOSTIC_TEST
Podiatry Ankle Duplex scan (PAD-scan)
DIAGNOSTIC_TEST
Lead Sponsor
Imperial College London
Collaborators
NCT07472049
NCT07161583
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07039396